We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANSS
76
DELISTED
Ansys
ANSS
$30M 0.32%
102,708
-21,770
-17% -$5.8M
T icon
77
AT&T
T
$168B
$29.7M 0.31%
1,300,435
-533,726
-29% -$12.2M
TECH icon
78
Bio-Techne
TECH
$11.2B
$29.4M 0.31%
445,180
-236,104
-35% -$14.1M
PANW icon
79
Palo Alto Networks
PANW
$262B
$29.1M 0.31%
760,140
-535,674
-41% -$18.9M
DG icon
80
Dollar General
DG
$27.4B
$29M 0.31%
152,442
+28,845
+23% +$5.22M
VMW
81
DELISTED
VMware, Inc
VMW
$29M 0.31%
187,173
+102,977
+122% +$14.2M
EMR icon
82
Emerson Electric
EMR
$83.1B
$28.7M 0.3%
463,242
+78,085
+20% +$4.44M
ARNA
83
DELISTED
Arena Pharmaceuticals Inc
ARNA
$28.6M 0.3%
454,075
+57,275
+14% +$3.15M
AWK icon
84
American Water Works
AWK
$26.3B
$28.5M 0.3%
221,426
+24,380
+12% +$3.04M
ASND icon
85
Ascendis Pharma A/S
ASND
$16.7B
$28.1M 0.3%
190,079
+78,079
+70% +$10.7M
SRPT icon
86
Sarepta Therapeutics
SRPT
$1.72B
$28M 0.3%
174,829
+9,729
+6% +$1.32M
TXN icon
87
Texas Instruments
TXN
$253B
$27.8M 0.29%
218,576
+39,725
+22% +$4.63M
ADP icon
88
Automatic Data Processing
ADP
$103B
$27.6M 0.29%
185,615
+133,906
+259% +$19.2M
ATVI
89
DELISTED
Activision Blizzard
ATVI
$27.6M 0.29%
363,023
-126,845
-26% -$8.85M
MELI icon
90
Mercado Libre
MELI
$93.2B
$27.5M 0.29%
27,924
+21,722
+350% +$16.3M
BNTX icon
91
BioNTech
BNTX
$23.2B
$27.4M 0.29%
+410,313
New +$20.5M
EA icon
92
Electronic Arts
EA
$52.4B
$27.1M 0.29%
204,851
-42,548
-17% -$5.03M
HALO icon
93
Halozyme
HALO
$9.69B
$26.7M 0.28%
996,878
+181,559
+22% +$4.1M
EDU icon
94
New Oriental
EDU
$7.91B
$26.3M 0.28%
202,087
+75,487
+60% +$9.2M
VAR
95
DELISTED
Varian Medical Systems, Inc.
VAR
$25.8M 0.27%
210,947
+74,480
+55% +$8.63M
ZGNX
96
DELISTED
Zogenix, Inc.
ZGNX
$25.6M 0.27%
947,329
+743,629
+365% +$20.5M
BLUE
97
DELISTED
bluebird bio
BLUE
$25.5M 0.27%
32,219
+13,856
+75% +$10.4M
KO icon
98
Coca-Cola
KO
$361B
$25.2M 0.27%
563,152
-97,540
-15% -$4.49M
ALNY icon
99
Alnylam Pharmaceuticals
ALNY
$37.6B
$24.8M 0.26%
167,600
-23,132
-12% -$3.12M
ON icon
100
ON Semiconductor
ON
$33.9B
$24.7M 0.26%
1,244,390
+78,685
+7% +$1.28M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.